Novo Nordisk's Wegovy weight-loss drug sales beat forecast, shares jump
Novo Nordisk reported forecast-beating third-quarter sales of its popular Wegovy weight-loss drug on Wednesday, reassuring investors worried that demand was slowing and it could lose the race in the fast-growing obesity drug market.
Counterfeit weight loss drugs sold online
The UK’s drug’s watchdog has warned people over the use of counterfeit medications which could contain insulin - with many ...
Novo Nordisk disclosed it knows of 10 deaths and 100 hospitalizations from people taking compounded copies of its weight loss ...
Wegovy: Approved for chronic weight management in adults with ... An oral form of semaglutide approved for improving ...
The NHS rollout of appetite suppressing injections has been thrown into doubt after what is believed to be the first confirmed death linked to the controversial drugs ...
Wegovy® is the only version of semaglutide that is FDA-approved for weight loss, while Ozempic® and other forms of the drug ...
Compounded semaglutide can be an affordable alternative to brand-name weight loss injections like Ozempic and Wegovy. But ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback